Moreover, our results indicated that EA effectively alleviated these depression- and anxiety-like behaviors, suppressed the expression of P2X7R/NLRP3/IL-1β, reduced the excessive activation of microglia in the PFC and macrophages in the liver, decreased the release of IL-1β, and regulated central and peripheral inflammation. Here, NLRP3 is linked to depressive symptom measurement.